日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Luteibacter mycovicinus sp. nov., a yellow-pigmented gammaproteobacterium found as an endohyphal symbiont of endophytic Ascomycota

黄杆菌(Luteibacter mycovicinus sp. nov.)是一种黄色色素γ-变形菌,是内生子囊菌的内菌丝共生菌。

Baltrus, David A; Carter, Morgan; Clark, Meara; Smith, Caitlin; Spraker, Joseph; Inderbitzin, Patrik; Arnold, A Elizabeth

Cancer survival stories: Perception, creation, and potential use case

癌症生存故事:认知、创造与潜在应用案例

Canella, Claudia; Inderbitzin, Martin; Oehler, Manuela; Witt, Claudia M; Barth, Jürgen

A Curious Case of Gastrointestinal Eosinophilia Induced by Treatment With Immune Checkpoint Inhibitors

免疫检查点抑制剂治疗诱发胃肠道嗜酸性粒细胞增多症的奇特病例

Reddy, Yala Kirthi; Fischer, Inderbitzin Sonya; Kolodney, Joanna; Willard, Megan

Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4(+) T cells: A pooled data-analysis

潜伏感染和再激活的HIV-1感染的原代CD4(+) T细胞的转录组谱:汇总数据分析

Inderbitzin, Anne; Loosli, Tom; Opitz, Lennart; Rusert, Peter; Metzner, Karin J

Severe portal and systemic acidosis during CO(2)-laparoscopy compared to helium or gasless laparoscopy and laparotomy in a rodent model: an experimental study

在啮齿动物模型中,与氦气或无气腹腔镜和开腹手术相比,二氧化碳腹腔镜手术期间出现严重的门静脉和全身性酸中毒:一项实验研究

Inderbitzin, Devdas T; Mueller, Tobias U; Marti, Grischa; Eichenberger, Simone; Fellay, Benoît; Magnin, Jean-Luc; Kraehenbuehl, Lukas

Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation

使用基于 CRISPR/Cas9 的新方法对 GSH AAVS1 中的转基因表达进行量化,揭示出高度的转录变异

Anne Inderbitzin, Tom Loosli, Roger D Kouyos, Karin J Metzner

Cu/Zn superoxide dismutase (VdSOD1) mediates reactive oxygen species detoxification and modulates virulence in Verticillium dahliae

Cu/Zn超氧化物歧化酶(VdSOD1)介导活性氧解毒并调节大丽轮枝菌的毒力

Li Tian, Junjiao Li, Caimin Huang, Dandan Zhang, Yan Xu, Xingyong Yang, Jian Song, Dan Wang, Nianwei Qiu, Dylan P G Short, Patrik Inderbitzin, Krishna V Subbarao, Jieyin Chen, Xiaofeng Dai

Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib

既往存在的心血管疾病会增加接受伊布替尼治疗的癌症患者发生房性心律失常和死亡的风险。

Avalon, Juan Carlo; Fuqua, Jacob; Miller, Tyler; Deskins, Seth; Wakefield, Chelby; King, Austin; Inderbitzin-Brooks, Sonya; Bianco, Christopher; Veltri, Lauren; Fang, Wei; Craig, Michael; Kanate, Abraham; Ross, Kelly; Malla, Midhun; Patel, Brijesh

Risk of malignancy in Caroli disease and syndrome: A systematic review

卡罗利病和综合征的恶性肿瘤风险:系统评价

Fahrner, René; Dennler, Sandra Gc; Inderbitzin, Daniel

Differential effect of cardiac resynchronization therapy in patients with diabetes mellitus: a long-term retrospective cohort study

心脏再同步治疗对糖尿病患者的差异性影响:一项长期回顾性队列研究

Kahr, Peter C; Trenson, Sander; Schindler, Matthias; Kuster, Joël; Kaufmann, Philippe; Tonko, Johanna; Hofer, Daniel; Inderbitzin, Devdas T; Breitenstein, Alexander; Saguner, Ardan M; Flammer, Andreas J; Ruschitzka, Frank; Steffel, Jan; Winnik, Stephan